Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Rahul Verma

Rahul Verma joined Medical Dialogues in the year 2022 and is currently working as a Video editor & Medical correspondent. He has completed his graduation in Bachelors of Arts (BA) from IGNOU. He likes to keep himself and the world updated on the occurring in the medical field. He can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Rahul Verma

Articles By : Rahul Verma

Intas Pharma bags CDSCO panel nod to study Human Normal Immunoglobulin

Rahul Verma26 July 2022 5:30 PM IST

Pharmaceutical major Intas Pharma has got the go-head from the Subject Expert Committee (SEC) functional under Central Drug Standard Control...

Sun Pharma, Glenmark recall products in US

Rahul Verma25 July 2022 5:28 PM IST

Leading drug makers Sun Pharma and Glenmark are recalling products in the US, the world's largest market for medicines, due to lapses in the...

Dr Reddy's Labs launches generic version of Allegra in US

Rahul Verma25 July 2022 1:04 PM IST

Drugmaker, Dr Reddy's Laboratories Ltd., has announced the first-to-market launch of over-the-counter (OTC) Fexofenadine HCl 180 mg and...

CDSCO panel nod to Novartis Ruxolitinib for acute and chronic graft versus host disease

Rahul Verma24 July 2022 2:15 PM IST

In response to the pharma major Novartis proposal for additional indication of Ruxolitinib Tablets 5/10/15/20 mg, the Subject Expert Committee (SEC)...

Govt launches 3 schemes for MSMEs in pharma sector

Rahul Verma22 July 2022 5:54 PM IST

The government on Thursday launched three schemes to strengthen Micro, Small and Medium Enterprises (MSMEs) in the pharmaceutical sector. Speaking at...

Covaxin booster dose increases immune response by 40 times: Bharat Biotech

Rahul Verma21 July 2022 6:00 PM IST

Bharat Biotech International Limited (BBIL), has announced that BBV152 (COVAXIN), its whole-virion inactivated COVID-19 vaccine, has proven to be...

Merck Keytruda fails head and neck cancer trial

Rahul Verma21 July 2022 5:00 PM IST

Merck, known as MSD outside the United States and Canada, has announced that the Phase 3 KEYNOTE-412 trial evaluating KEYTRUDA (pembrolizumab),...

PharmEasy plans to raise USD 200 million at lower valuations

Rahul Verma20 July 2022 5:00 PM IST

Indian drug and medical services startup PharmEasy is in talks with investors to raise $200 million, but at a valuation that could be 15% or even 25%...

India crosses 200 crore mark in COVID vaccination

Rahul Verma19 July 2022 2:31 PM IST

In a historic achievement, India's cumulative COVID19 vaccination drive has surpassed the 200-Crore milestone. As per provisional reports till 1 pm on...

After dengue scare, now Telangana battles with tomato flu

Rahul Verma18 July 2022 6:00 PM IST

In the ongoing battle with diseases like dengue and typhoid, Telangana has been also a victim of tomato flu, which takes its name after the blisters...

USFDA mulls to approve first ever OTC birth control pill

Rahul Verma15 July 2022 5:43 PM IST

Amid the US Supreme Court's decision to ban abortion in the country, the Food and Drug Administration is considering to approve the first-ever over...

Cipla Health to acquire Endura Mass from Medinnbelle Hervalcare

Rahul Verma15 July 2022 4:58 PM IST

Cipla Limited has announced that Cipla Health Limited (CHL), wholly owned subsidiary and consumer healthcare arm of the Company has signed definitive...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok